Financial Gravity Asset Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-12
Closed -$510 2006
2023
Q4
$510 Buy
12
+6
+100% +$292 ﹤0.01% 1154
2023
Q3
$235 Buy
+6
New +$336 ﹤0.01% 930
2023
Q2
Sell
-57
Closed -$2.23K 1714
2023
Q1
$2.23K Buy
+57
New +$3.65K 0.07% 288
2022
Q4
Sell
-180
Closed -$197 1485
2022
Q3
$197 Buy
+180
New +$10.8K 0.01% 553
2021
Q4
Sell
-3
Closed -$77K 979
2021
Q3
$77K Hold
3
0.04% 432
2021
Q2
$78K Buy
+3
New +$213 0.03% 422
2019
Q4
Sell
-244
Closed -$12K 1511
2019
Q3
$12K Sell
244
-351
-59% -$16.7K 0.01% 570
2019
Q2
$25K Buy
+595
New +$25.8K 0.02% 445
2018
Q3
$47K Buy
+905
New +$47.6K 0.05% 341

Other funds holding GMED

Financial Gravity Asset Management's GMED Position: Q1 2024 in Review

Financial Gravity Asset Management sold out of Globus Medical (GMED) in Q1 2024, closing a stake of 12 shares — an estimated $510 sold.

Financial Gravity Asset Management first reported a position in GMED in Q3 2018 and held it in 9 quarters. The position peaked at $78K in Q2 2021. 439 funds tracked by Wall St. Rank hold GMED as of Q1 2024.

  • Financial Gravity Asset Management reported no remaining Globus Medical position as of Q1 2024 after selling out during the quarter.
  • Financial Gravity Asset Management sold 12 Globus Medical shares in Q1 2024, an estimated $510.
  • Financial Gravity Asset Management first reported a position in Globus Medical in Q3 2018 and held it in 9 quarters.
  • Financial Gravity Asset Management's Globus Medical position peaked at $78K in Q2 2021.
  • 439 funds tracked by Wall St. Rank held Globus Medical as of Q1 2024.

Based on Financial Gravity Asset Management's 13F filing for Q1 2024, filed 13 May 2024.